📊 HTFL Key Takeaways
Is Heartflow, Inc. (HTFL) a Good Investment?
HeartFlow demonstrates strong top-line growth (39.9% YoY) and exceptional gross margins (80.2%), indicating solid product-market fit in the medical device sector. However, the company faces critical execution risk with negative operating cash flow of -$30.1M and only $19.7M in cash on hand, providing just 2-3 months of runway at current burn rates. Success depends on rapid operational leverage improvement or capital raise to extend runway while margins expand.
HeartFlow is growing quickly (~40% YoY) with a very strong gross margin (~77%), indicating attractive unit economics. However, profitability remains distant with deep operating and net losses and meaningful cash burn; cash of ~$45M versus -$59M FCF suggests a limited runway without improvement or financing. Maintain a neutral stance until revenue growth translates into operating leverage and positive cash flow.
Why Buy Heartflow, Inc. Stock? HTFL Key Strengths
- Strong revenue growth of 39.9% YoY demonstrates market traction and adoption
- Exceptional gross margin of 80.2% indicates strong pricing power and product-market fit
- Fortress balance sheet with $285.7M equity, zero debt, and excellent liquidity (5.57x current ratio) provides financial flexibility
- Improving loss per share (+82.4% YoY) shows cost structure moving toward profitability
- Rapid revenue growth (~40% YoY)
- Very high gross margin (~77%) supporting strong unit economics
- Debt-free with strong liquidity (current ratio ~5.2x)
HTFL Stock Risks: Heartflow, Inc. Investment Risks
- Unsustainable cash burn: -$30.1M operating cash flow with only $19.7M cash on hand (~2-3 months runway)
- Deep operating losses (-$56.1% margin) indicate significant operating expense burden relative to revenue scale
- Negative free cash flow (-$32.0M) suggests business model requires substantial growth or restructuring to achieve cash generation
- Dilution risk: Company will likely need to raise capital or access debt markets, reducing shareholder value if not at favorable terms
- Large ongoing operating and net losses; path to profitability uncertain
- Negative FCF and short cash runway relative to burn, implying potential dilution/financing needs
- Operating expenses outpacing gross profit, delaying operating leverage
Key Metrics to Watch
- Operating margin trajectory toward breakeven (currently -56.1%)
- Cash burn rate and runway duration relative to revenue growth acceleration
- Operating cash flow inflection point as company scales
- Capital raise activity and dilution impact on existing shareholders
- Operating cash flow and FCF burn/runway
- Operating margin improvement (opex as % of revenue)
Heartflow, Inc. (HTFL) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 5.57x current ratio provides a solid financial cushion.
HTFL Profit Margin, ROE & Profitability Analysis
HTFL vs Healthcare Sector: How Heartflow, Inc. Compares
How Heartflow, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Heartflow, Inc. Stock Overvalued? HTFL Valuation Analysis 2026
Based on fundamental analysis, Heartflow, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Heartflow, Inc. Balance Sheet: HTFL Debt, Cash & Liquidity
HTFL Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Heartflow, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-25.32 indicates the company is currently unprofitable.
HTFL Revenue Growth, EPS Growth & YoY Performance
HTFL Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $37.2M | -$27.4M | $-0.32 |
| Q3 2025 | $32.9M | -$9.2M | $-1.04 |
| Q2 2025 | $31.1M | -$9.2M | $-1.46 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Heartflow, Inc. Dividends, Buybacks & Capital Allocation
HTFL SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Heartflow, Inc. (CIK: 0001464521)
📋 Recent SEC Filings
❓ Frequently Asked Questions about HTFL
What is the AI rating for HTFL?
Heartflow, Inc. (HTFL) has a Combined AI Rating of HOLD from Claude (HOLD) and ChatGPT (HOLD) with 66% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are HTFL's key strengths?
Claude: Strong revenue growth of 39.9% YoY demonstrates market traction and adoption. Exceptional gross margin of 80.2% indicates strong pricing power and product-market fit. ChatGPT: Rapid revenue growth (~40% YoY). Very high gross margin (~77%) supporting strong unit economics.
What are the risks of investing in HTFL?
Claude: Unsustainable cash burn: -$30.1M operating cash flow with only $19.7M cash on hand (~2-3 months runway). Deep operating losses (-$56.1% margin) indicate significant operating expense burden relative to revenue scale. ChatGPT: Large ongoing operating and net losses; path to profitability uncertain. Negative FCF and short cash runway relative to burn, implying potential dilution/financing needs.
What is HTFL's revenue and growth?
Heartflow, Inc. reported revenue of $52.6M.
Does HTFL pay dividends?
Heartflow, Inc. does not currently pay dividends.
Where can I find HTFL SEC filings?
Official SEC filings for Heartflow, Inc. (CIK: 0001464521) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is HTFL's EPS?
Heartflow, Inc. has a diluted EPS of $-0.32.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is HTFL a good stock to buy right now?
Based on our AI fundamental analysis in May 2026, Heartflow, Inc. has a HOLD rating with 66% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is HTFL stock overvalued or undervalued?
Valuation metrics for HTFL: ROE of -9.6% (sector avg: 15%), net margin of -52.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy HTFL stock in 2026?
Our dual AI analysis gives Heartflow, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is HTFL's free cash flow?
Heartflow, Inc.'s operating cash flow is $-30.1M, with capital expenditures of $1.9M. FCF margin is -60.8%.
How does HTFL compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -52.1% (avg: 12%), ROE -9.6% (avg: 15%), current ratio 5.57 (avg: 2).